1 active not recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
Follow Standard ET followed by change in treatment: new trials by email Literature Review of Standard ET followed by change in treatment trials Research Report on Standard ET followed by change in treatment
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A PoC Study to Evaluate Treatments' Efficacy by Monitoring MRD Using ctDNA in HR-positive/HER2-negative EBC Population Giredestrant, Abemaciclib, Inavolisib - Breast Cancer | Phase 2 | Active not recruiting | MedSIR | 976 | 2024-04-01 | 2026-09-24 |
Breast Neoplasms (1) · Neoplasm, Residual (1)
MedSIR (1)
Spain (1) · United Kingdom (1)
2023 (1)